Avenda Health utilizes artificial intelligence to create a Cancer Estimation Map (CEM) that accurately visualizes the location and extent of prostate cancer, significantly enhancing treatment planning. This technology helps physicians make informed decisions, reducing the likelihood of residual cancer and preserving patients' quality of life.

ConKay Medical Systems develops medical devices specifically designed to treat valvular regurgitation in patients suffering from progressive heart failure. Their technology aims to improve patient outcomes by addressing the complications associated with this condition, enhancing cardiovascular care.

FastWave Medical develops next-generation intravascular lithotripsy (IVL) systems designed to treat calcific artery disease. Their platforms offer advanced balloon catheter technology for both peripheral artery disease and coronary artery disease interventions. These systems provide interventionalists with predictable sonic output and enhanced procedural feedback for calcium modification.

The startup specializes in drill-free, patient-specific dental implants using three-dimensional scanning and design technology. This approach provides a safe and efficient solution for individuals experiencing tooth loss, ensuring a faster and more accessible treatment process.

Inhalon Biopharma is developing inhaled monoclonal antibody treatments for acute respiratory infections, including RSV and SARS-CoV-2, utilizing a novel inhalation delivery system. This approach aims to enhance treatment effectiveness and provide a convenient "test-to-treat" model for patients, facilitating timely and accessible respiratory care.

Jupiter Endovascular develops endovascular devices utilizing Transforming Fixation (TFX) technology, which allows catheters to transition between flexible and firm states during procedures. This innovation aims to simplify complex interventions in soft vascular structures, initially targeting pulmonary embolism treatment. The technology seeks to expand therapeutic options for cardiovascular conditions currently underserved by existing catheter systems.

Leadoptik develops microstructure imaging technology for interventional pulmonology procedures. Their LIA system provides real-time nodule assessment to enhance the precision of biopsy needle placement during minimally invasive procedures. This technology aims to narrow the knowledge gap and improve diagnostic accuracy in interventional pulmonology.

Provides a clear aligner system combining FDA-cleared night-only wear NiTime Aligners™ and stain-resistant Bright Aligners™ to straighten and whiten teeth simultaneously. This approach offers a discreet, comfortable, and efficient alternative to traditional braces, treating various orthodontic issues while allowing patients to eat, drink, and speak without restrictions during the day.

Socialtrait develops AI-driven predictive analytics tools that simulate consumer behavior through the creation of diverse AI personas, enabling businesses to gain objective insights into audience preferences and content performance. This technology addresses the inefficiencies and biases of traditional market research by providing rapid, cost-effective, and scalable solutions for data analysis and strategy refinement.

Vantis Vascular develops a dual-catheter system designed to enhance the delivery of therapeutic devices through complex, calcified, and tortuous vascular anatomies. This technology addresses the challenge of advancing guide catheters in over 20% of percutaneous coronary interventions, improving procedural efficiency and patient safety.

Ventaris develops investigational medical devices intended for surgical applications. These products are currently limited to investigational use only and are not approved or cleared by the FDA or other regulatory bodies for commercial sale. The company focuses on creating new technologies for the medical device market.